Key Takeaways BASF sells its Aseptrol technology portfolio to Oxidium Technologies to streamline focus on core segments.BASFY aligns divestment with its "Winning Ways" strategy, targeting growth in core areas.Oxidium plans to expand Aseptrol's reach using existing networks, with no disruption to supply or services.BASF SE (BASFY) recently entered into an agreement with Oxidium Technologies LLC to sell its Aseptrol technology portfolio, marking a strategic step in sharpening its focus by supporting growth in ...